References
- American Thoracic SocietyIdiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)Am J Respir Crit Care Med20001612 Pt 164666410673212
- RaghuGCollardHREganJJATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary FibrosisAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementAm J Respir Crit Care Med2011183678882421471066
- KingTEJrPardoASelmanMIdiopathic pulmonary fibrosisLancet201137898071949196121719092
- NoblePWAlberaCBradfordWZCAPACITY Study GroupPirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsLancet201137797791760176921571362
- HammanLRichARAcute diffuse interstitial fibrosis of the lungsBull Johns Hopkins Hospital194474177212
- KatzensteinALMyersJLIdiopathic pulmonary fibrosis: clinical relevance of pathologic classificationAm J Respir Crit Care Med19981574 Pt 1130113159563754
- CoultasDBHughesMPAccuracy of mortality data for interstitial lung diseases in New Mexico, USAThorax19965177177208882079
- KarakatsaniAPapakostaDRaptiAHellenic Interstitial Lung Diseases GroupEpidemiology of interstitial lung diseases in GreeceRespir Med200910381122112919345567
- MusellimBOkumusGUzaslanETurkish Interstitial Lung Diseases Group. Epidemiology and distribution of interstitial lung diseases in TurkeyClin Respir J Epub5272013
- ThomeerMJCostabeURizzatoGPolettiVDemedtsMComparison of registries of interstitial lung diseases in three European countriesEur Respir J Suppl200132114s118s11816817
- OhnoSNakayaTBandoMSugiyamaYIdiopathic pulmonary fibrosis – results from a Japanese nationwide epidemiological survey using individual clinical recordsRespirology200813692692818657060
- CoultasDBZumwaltREBlackWCSobonyaREThe epidemiology of interstitial lung diseasesAm J Respir Crit Care Med199415049679727921471
- RaghuGWeyckerDEdelsbergJBradfordWZOsterGIncidence and prevalence of idiopathic pulmonary fibrosisAm J Respir Crit Care Med2006174781081616809633
- Fernández PérezERDanielsCESchroederDRIncidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based studyChest2010137112913719749005
- GribbinJHubbardRBLe JeuneISmithCJWestJTataLJIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKThorax2006611198098516844727
- NavaratnamVFlemingKMWestJThe rising incidence of idiopathic pulmonary fibrosis in the UKThorax201166646246721525528
- KolekVEpidemiology of cryptogenic fibrosing alveolitis in Moravia and SilesiaActa Univ Palacki Olomuc Fac Med199413749507778506
- von PlessenCGrindeOGulsvikAIncidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian communityRespir Med200397442843512693805
- HodgsonULaitinenTTukiainenPNationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in FinlandThorax200257433834211923553
- LaiCCWangCYLuHMIdiopathic pulmonary fibrosis in Taiwan – a population-based studyRespir Med2012106111566157422954482
- HubbardRVennALewisSBrittonJLung cancer and cryptogenic fibrosing alveolitis. A population-based cohort studyAm J Respir Crit Care Med200016115810619790
- ManninoDMEtzelRAParrishRGPulmonary fibrosis deaths in the United States, 1979–1991. An analysis of multiple-cause mortality dataAm J Respir Crit Care Med19961535154815528630600
- OlsonALSwigrisJJLezotteDCNorrisJMWilsonCGBrownKKMortality from pulmonary fibrosis increased in the United States from 1992 to 2003Am J Respir Crit Care Med2007176327728417478620
- TaskarVSCoultasDBIs idiopathic pulmonary fibrosis an environmental disease?Proc Am Thorac Soc20063429329816738192
- JohnstonIDPrescottRJChalmersJCRuddRMBritish Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic SocietyThorax199752138449039238
- JohnstonIBrittonJKinnearWLoganRRising mortality from cryptogenic fibrosing alveolitisBMJ19903016759101710212249048
- ArakawaHJohkohTHonmaKChronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: its prevalence and comparison of CT findings with idiopathic pulmonary fibrosisChest200713161870187617400659
- CopleySJWellsAUSivakumaranPAsbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT featuresRadiology2003229373173614576443
- KitamuraHIchinoseSHosoyaTInhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis – elemental microanalysis of pulmonary lymph nodes obtained at autopsy casesPathol Res Pract2007203857558517590529
- ScottJJohnstonIBrittonJWhat causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dustBMJ1990301101510172249047
- IwaiKMoriTYamadaNYamaguchiMHosodaYIdiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposureAm J Respir Crit Care Med199415036706758087336
- HubbardRLewisSRichardsKJohnstonIBrittonJOccupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitisLancet199634789972842898569361
- MullenJHodgsonMDeGraffAGodarTCase-control study of idiopathic pulmonary fibrosis and environmental exposuresJ Occup Environ Med19984043633679571528
- BaumgartnerKBSametJMCoultasDBOccupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating CentersAm J Epidemiol2000152430731510968375
- MiyakeYSasakiSYokoyamaTOccupational and environmental factors and idiopathic pulmonary fibrosis in JapanAnn Occup Hyg200549325926515640309
- BaumgartnerKBSametJMStidleyCAColbyTVWaldronJACigarette smoking: a risk factor for idiopathic pulmonary fibrosisAm J Respir Crit Care Med199715512422489001319
- SteeleMPSpeerMCLoydJEClinical and pathologic features of familial interstitial pneumoniaAm J Respir Crit Care Med200517291146115216109978
- HubbardRCooperMAntoniakMRisk of cryptogenic fibrosing alveolitis in metal workersLancet2000355920246646710841131
- GustafsonTDahlman-HöglundANilssonKStrömKTornlingGTorénKOccupational exposure and severe pulmonary fibrosisRespir Med2007101102207221217628464
- PinheiroGAAntaoVCWoodJMWassellJTOccupational risks for idiopathic pulmonary fibrosis mortality in the United StatesInt J Occup Environ Health200814211712318507288
- García-SanchoCBuendía-RoldánIFernández-PlataMRFamilial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosisRespir Med2011105121902190721917441
- AwadallaNJHegazyAElmetwallyRAWahbyIOccupational and environmental risk factors for idiopathic pulmonary fibrosis in Egypt: a multicenter case-control studyInt J Occup Environ Med20123310711623022860
- LeeJSCollardHRRaghuGDoes chronic microaspiration cause idiopathic pulmonary fibrosis?Am J Med2010123430431120362747
- TobinRWPopeCEPellegriniCAEmondMJSilleryJRaghuGIncreased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med19981586180418089847271
- RaghuGFreudenbergerTDYangSHigh prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosisEur Respir J200627113614216387946
- PattiMGTedescoPGoldenJIdiopathic pulmonary fibrosis: how often is it really idiopathic?J Gastrointest Surg20059810531058 discussion 1056–105816269375
- GribbinJHubbardRSmithCRole of diabetes mellitus and gastrooesophageal reflux in the aetiology of idiopathic pulmonary fibrosisRespir Med2009103692793119058956
- LeeJSRyuJHElickerBMGastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med2011184121390139421700909
- LeeJSCollardHRAnstromKJAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomized controlled trialsLancet Respir Med201315369376
- DevineMSGarciaCKGenetic interstitial lung diseaseClin Chest Med20123319511022365249
- LeeHLRyuJHWittmerMHFamilial idiopathic pulmonary fibrosis: clinical features and outcomeChest200512762034204115947317
- ArmaniosMYChenJJCoganJDTelomerase mutations in families with idiopathic pulmonary fibrosisN Engl J Med2007356131317132617392301
- TsakiriKDCronkhiteJTKuanPJAdult-onset pulmonary fibrosis caused by mutations in telomeraseProc Natl Acad Sci U S A2007104187552755717460043
- NogeeLMDunbarAE3rdWertSEAskinFHamvasAWhitsettJAA mutation in the surfactant protein C gene associated with familial interstitial lung diseaseN Engl J Med2001344857357911207353
- ThomasAQLaneKPhillipsJHeterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindredAm J Respir Crit Care Med200216591322132811991887
- van MoorselCHvan OosterhoutMFBarloNPSurfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohortAm J Respir Crit Care Med2010182111419142520656946
- WangYKuanPJXingCGenetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancerAm J Hum Genet2009841525919100526
- HodgsonUPulkkinenVDixonMELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosisAm J Hum Genet200679114915416773575
- MushirodaTWattanapokayakitSTakahashiAPirfenidone Clinical Study GroupA genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosisJ Med Genet2008451065465618835860
- CronkhiteJTXingCRaghuGTelomere shortening in familial and sporadic pulmonary fibrosisAm J Respir Crit Care Med2008178772973718635888
- Diaz de LeonACronkhiteJTKatzensteinALTelomere lengths, pulmonary fibrosis and telomerase (TERT) mutationsPLoS One201055e1068020502709
- SeiboldMAWiseALSpeerMCA common MUC5B promoter polymorphism and pulmonary fibrosisN Engl J Med2011364161503151221506741
- ZhangYNothIGarciaJGKaminskiNA variant in the promoter of MUC5B and idiopathic pulmonary fibrosisN Engl J Med2011364161576157721506748
- PeljtoALZhangYFingerlinTEAssociation between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosisJAMA2013309212232223923695349
- FingerlinTEMurphyEZhangWGenome-wide association study identifies multiple susceptibility loci for pulmonary fibrosisNat Genet201345661362023583980
- NothIZhangYMaSFGenetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genomewide association studyLancet Respir Med201314309317
- AlmagroPCalboEOchoa de EchagüenAMortality after hospitalization for COPDChest200212151441144812006426
- MartinezFJSafrinSWeyckerDIPF Study GroupThe clinical course of patients with idiopathic pulmonary fibrosisAnn Intern Med200514212 Pt 196396715968010
- SongJWHongSBLimCMKohYKimDSAcute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcomeEur Respir J201137235636320595144
- du BoisRMWeyckerDAlberaCAscertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosisAm J Respir Crit Care Med2011184445946621616999
- CollardHRMooreBBFlahertyKRIdiopathic Pulmonary Fibrosis Clinical Research Network InvestigatorsAcute exacerbations of idiopathic pulmonary fibrosisAm J Respir Crit Care Med2007176763664317585107
- NavaratnamVFogartyAWGlendeningRMcKeeverTHubbardRBThe increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010Chest201314341078108423188187
- CollardHRWardAJLanesSCortney HayfingerDRosenbergDMHunscheEBurden of illness in idiopathic pulmonary fibrosisJ Med Econ201215582983522455577
- HubbardRJohnstonICoultasDBBrittonJMortality rates from cryptogenic fibrosing alveolitis in seven countriesThorax19965177117168882078
- SwigrisJJOlsonALHuieTJEthnic and racial differences in the presence of idiopathic pulmonary fibrosis at deathRespir Med2012106458859322296740
- HowladerNNooneAMKrapchoMSEER Cancer Statistics Review, 1975–2010 [webpage on the Internet]Bethesda, MDNational Cancer Institute2012 [updated June 14, 2013]. Available from: http://seer.cancer.gov/csr/1975_2010/, 2013Accessed August 16, 2013